CASTELLETTI, SEFORA
 Distribuzione geografica
Continente #
NA - Nord America 634
EU - Europa 351
AS - Asia 125
AF - Africa 20
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.134
Nazione #
US - Stati Uniti d'America 632
IT - Italia 109
SE - Svezia 59
UA - Ucraina 56
SG - Singapore 54
IE - Irlanda 42
CN - Cina 37
DE - Germania 26
CI - Costa d'Avorio 20
DK - Danimarca 19
TR - Turchia 16
GB - Regno Unito 14
KR - Corea 11
FI - Finlandia 10
FR - Francia 7
VN - Vietnam 4
NL - Olanda 3
RU - Federazione Russa 3
AU - Australia 2
MX - Messico 2
AR - Argentina 1
AT - Austria 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
PK - Pakistan 1
RO - Romania 1
Totale 1.134
Città #
Chandler 119
Jacksonville 62
Ashburn 51
Dublin 42
Fairfield 41
Boardman 36
Singapore 22
Abidjan 20
Ann Arbor 20
Wilmington 20
Woodbridge 20
New York 19
Seattle 19
Turin 18
Lawrence 17
Princeton 17
San Mateo 13
Des Moines 12
Redmond 12
Ancona 11
Centro 11
Beijing 9
Houston 9
Cambridge 7
Napoli 7
Rome 7
Cagliari 6
Washington 5
Ho Chi Minh City 4
San Diego 4
Dallas 3
Jiaxing 3
London 3
Los Angeles 3
Marche 3
Mountain View 3
Salerno 3
Amsterdam 2
Bologna 2
Cameri 2
Copertino 2
Fiesole 2
Filottrano 2
Lucca 2
Milan 2
Monterrey 2
Nanjing 2
Norwalk 2
Pisa 2
San Severino Marche 2
Sant'Elpidio a Mare 2
Wuhan 2
Wuxi 2
Acton 1
Adelaide 1
Buenos Aires 1
Changzhou 1
Chiaravalle 1
Chiswick 1
Cingoli 1
Esanatoglia 1
Gatchina 1
Guangzhou 1
Helsinki 1
Hounslow 1
Hwang Chow 1
Islamabad 1
Kagoya 1
Kilburn 1
Kupang 1
Mcallen 1
Melbourne 1
Montesilvano 1
Nürnberg 1
Palermo 1
Pesaro 1
Porto 1
San Benedetto Del Tronto 1
Santa Clara 1
Shanghai 1
St Petersburg 1
Suceava 1
Taiyuan 1
Tolentino 1
Vienna 1
Yekaterinburg 1
Zagreb 1
Totale 747
Nome #
La resistenza agli antibiotici in Pseudomonas aeruginosa: studio molecolare ed epidemiologico in un nosocomio marchigiano 105
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 103
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 93
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 73
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 68
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 68
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 68
Efficacy and costs of Direct Acting Antivirals (DAAS) for the treatment of HCV Iinfection amnog HCV-monoinfected and HIV/HCV co-infected patients in real-life setting 65
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 63
Direct acting antivirals (DAAs) for the treatment of HCV infection in HIV/HCV coinfected patients: a clinical experience. 58
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 57
In vitro activity of the lipopetide derivative (Pal-lys-lysNh2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes 52
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 50
null 47
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection. 43
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 42
null 39
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 35
Antiretroviral therapy management and rationalisation of available resources 29
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 9
Totale 1.167
Categoria #
all - tutte 6.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 0 0 16 0 12 1 16 27 6 14
2020/2021162 12 17 23 3 15 6 30 5 18 8 21 4
2021/2022137 4 31 1 8 3 2 14 10 12 5 14 33
2022/2023311 25 35 30 21 30 37 1 25 69 1 32 5
2023/2024195 25 12 17 28 31 41 3 14 3 6 4 11
2024/2025128 66 29 17 10 6 0 0 0 0 0 0 0
Totale 1.167